Optoregulated Drug Release from an Engineered Living Material: Self‐Replenishing Drug Depots for Long‐Term, Light‐Regulated Delivery

On‐demand and long‐term delivery of drugs are common requirements in many therapeutic applications, not easy to be solved with available smart polymers for drug encapsulation. This work presents a fundamentally different concept to address such scenarios using a self‐replenishing and optogenetically...

Full description

Saved in:
Bibliographic Details
Published in:Small (Weinheim an der Bergstrasse, Germany) Germany), 2019-02, Vol.15 (5), p.e1804717-n/a
Main Authors: Sankaran, Shrikrishnan, Becker, Judith, Wittmann, Christoph, del Campo, Aránzazu
Format: Article
Language:English
Subjects:
Bacteria
controlled release
deoxyviolacein
Drug delivery systems
E coli
Hydrogels
Light beams
living materials
metabolic engineering
Nanotechnology
optogenetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:On‐demand and long‐term delivery of drugs are common requirements in many therapeutic applications, not easy to be solved with available smart polymers for drug encapsulation. This work presents a fundamentally different concept to address such scenarios using a self‐replenishing and optogenetically controlled living material. It consists of a hydrogel containing an active endotoxin‐free Escherichia coli strain. The bacteria are metabolically and optogenetically engineered to secrete the antimicrobial and antitumoral drug deoxyviolacein in a light‐regulated manner. The permeable hydrogel matrix sustains a viable and functional bacterial population and permits diffusion and delivery of the synthesized drug to the surrounding medium at quantities regulated by light dose. Using a focused light beam, the site for synthesis and delivery of the drug can be freely defined. The living material is shown to maintain considerable levels of drug production and release for at least 42 days. These results prove the potential and flexibility that living materials containing engineered bacteria can offer for advanced therapeutic applications. A living material for prolonged and light‐controlled drug release. Metabolically and optogenetically engineered Escherichia coli is encapsulated within an agarose‐based hydrogel matrix to produce and release deoxyviolacein, an antimicrobial and antitumoral drug, in response to blue light irradiation. Localized, tunable, and prolonged drug release over 42 days is demonstrated.
ISSN:1613-6810
1613-6829
DOI:10.1002/smll.201804717